Study of Weekly LOC-paclitaxel Injection for Melanoma
NCT01039844
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
37
Enrollment
OTHER
Sponsor class
Stopped
Poor Accrual
Conditions
Melanoma
Interventions
DRUG:
LOC-paclitaxel
Sponsor
M.D. Anderson Cancer Center
Collaborators
[object Object]